Figure 1.
Distribution of primary disease–related characteristics in pediatric tAML. (A) Distribution of primary diseases preceding tAML in 119 pediatric patients, classified according to the International Classification of Childhood Cancer-3 (ICCC-3). (B) Age at primary disease (blue) and latency period to tAML (orange) in years by different antecedent diseases. ICCC-3 XI others includes 2 patients previously diagnosed with squamous cell carcinoma and hemophagocytic lymphohistiocytosis.

Distribution of primary disease–related characteristics in pediatric tAML. (A) Distribution of primary diseases preceding tAML in 119 pediatric patients, classified according to the International Classification of Childhood Cancer-3 (ICCC-3). (B) Age at primary disease (blue) and latency period to tAML (orange) in years by different antecedent diseases. ICCC-3 XI others includes 2 patients previously diagnosed with squamous cell carcinoma and hemophagocytic lymphohistiocytosis.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal